The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Classic Zinc Finger
".
FunFam 37: B-cell lymphoma/leukemia 11A isoform X1
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 22 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
| GO Term | Annotations | Evidence |
|---|---|---|
|
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
32 |
Q13422 (/ISA)
Q13422 (/ISA)
Q13422 (/ISA)
Q13422 (/ISA)
Q13422 (/ISA)
Q13422 (/ISA)
Q13422 (/ISA)
Q13422 (/ISA)
Q13422 (/ISA)
Q13422 (/ISA)
(22 more) |
|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
17 |
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
(7 more) |
|
Protein domain specific binding GO:0019904
Interacting selectively and non-covalently with a specific domain of a protein.
|
17 |
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
Q13422 (/IPI)
(7 more) |
|
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
14 |
Q13422 (/NAS)
Q13422 (/NAS)
Q13422 (/NAS)
Q13422 (/NAS)
Q13422 (/NAS)
Q13422 (/NAS)
Q13422 (/NAS)
Q13422 (/NAS)
Q13422 (/NAS)
Q13422 (/NAS)
(4 more) |
|
RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter of a gene transcribed by RNA polymerase II. The proximal promoter is in cis with and relatively close to the core promoter.
|
13 |
Q99PV8 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
(3 more) |
|
DNA-binding transcription repressor activity, RNA polymerase II-specific GO:0001227
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to repress or decrease transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
12 |
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
(2 more) |
|
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
12 |
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
(2 more) |
|
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
|
12 |
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
(2 more) |
|
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
|
5 | Q9H2S9 (/TAS) Q9H2S9 (/TAS) Q9H2S9 (/TAS) Q9H2S9 (/TAS) Q9H2S9 (/TAS) |
|
Zinc ion binding GO:0008270
Interacting selectively and non-covalently with zinc (Zn) ions.
|
5 | Q9H2S9 (/IMP) Q9H2S9 (/IMP) Q9H2S9 (/IMP) Q9H2S9 (/IMP) Q9H2S9 (/IMP) |
|
RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter of a gene transcribed by RNA polymerase II. The proximal promoter is in cis with and relatively close to the core promoter.
|
1 | Q9QYE3 (/ISO) |
|
DNA-binding transcription repressor activity, RNA polymerase II-specific GO:0001227
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to repress or decrease transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
1 | Q9QYE3 (/ISO) |
|
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
|
1 | Q99PV8 (/IDA) |
|
Transcription corepressor activity GO:0003714
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to repress the transcription of specific genes. Corepressors often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. A third class occludes DNA-binding transcription factor protein-protein interaction domains. A fourth class of corepressors prevents interactions of DNA bound DNA-binding transcription factor with coactivators.
|
1 | Q9QYE3 (/IDA) |
|
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
1 | D3ZSY3 (/IPI) |
|
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
1 | Q9QYE3 (/ISO) |
|
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
1 | P81183 (/IPI) |
|
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
1 | A2VDW9 (/ISS) |
|
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
|
1 | Q99PV8 (/IDA) |
|
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
|
1 | A2VDW9 (/ISS) |
|
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
1 | Q9QYE3 (/ISO) |
|
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
1 | A2VDW9 (/ISS) |
There are 67 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
| GO Term | Annotations | Evidence |
|---|---|---|
|
Protein heterooligomerization GO:0051291
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers that are not all identical. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
17 |
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
(7 more) |
|
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
12 |
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
Q9H165 (/IDA)
(2 more) |
|
Mesoderm development GO:0007498
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
|
12 |
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
Q13422 (/TAS)
(2 more) |
|
Protein sumoylation GO:0016925
The process in which a SUMO protein (small ubiquitin-related modifier) is conjugated to a target protein via an isopeptide bond between the carboxy-terminus of SUMO with an epsilon-amino group of a lysine residue of the target protein.
|
12 |
Q9H165 (/ISS)
Q9H165 (/ISS)
Q9H165 (/ISS)
Q9H165 (/ISS)
Q9H165 (/ISS)
Q9H165 (/ISS)
Q9H165 (/ISS)
Q9H165 (/ISS)
Q9H165 (/ISS)
Q9H165 (/ISS)
(2 more) |
|
Lymphocyte differentiation GO:0030098
The process in which a relatively unspecialized precursor cell acquires specialized features of a lymphocyte. A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin.
|
12 |
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
(2 more) |
|
Erythrocyte differentiation GO:0030218
The process in which a myeloid precursor cell acquires specializes features of an erythrocyte.
|
12 |
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
(2 more) |
|
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
12 |
Q13422 (/ISS)
Q13422 (/ISS)
Q13422 (/ISS)
Q13422 (/ISS)
Q13422 (/ISS)
Q13422 (/ISS)
Q13422 (/ISS)
Q13422 (/ISS)
Q13422 (/ISS)
Q13422 (/ISS)
(2 more) |
|
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
5 | Q9H2S9 (/TAS) Q9H2S9 (/TAS) Q9H2S9 (/TAS) Q9H2S9 (/TAS) Q9H2S9 (/TAS) |
|
Protein homooligomerization GO:0051260
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
5 | Q9H2S9 (/IMP) Q9H2S9 (/IMP) Q9H2S9 (/IMP) Q9H2S9 (/IMP) Q9H2S9 (/IMP) |
|
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
3 | Q99PV8 (/IMP) Q9C0K0 (/IMP) Q9C0K0 (/IMP) |
|
Brain development GO:0007420
The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
|
2 | A2BE84 (/IMP) Q1RLR5 (/IMP) |
|
Hematopoietic stem cell migration GO:0035701
The orderly movement of a hematopoietic stem cell from one site to another. A hematopoietic stem cell is a cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system.
|
2 | Q9C0K0 (/IMP) Q9C0K0 (/IMP) |
|
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P81183 (/IDA) Q99PV8 (/IDA) |
|
Lymphoid lineage cell migration into thymus GO:0097535
The movement of a lymphoid lineage cell (also called a lymphoid lineage restricted progenitor cell) into the thymus. Lymphoid lineage cells enter and exit the thymus several times as part of this process.
|
2 | Q9C0K0 (/IMP) Q9C0K0 (/IMP) |
|
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
1 | Q9QYE3 (/ISO) |
|
Keratinocyte development GO:0003334
The process whose specific outcome is the progression of a keratinocyte over time, from its formation to the mature structure.
|
1 | Q99PV8 (/IMP) |
|
Epithelial cell morphogenesis GO:0003382
The change in form that occurs when an epithelial cell progresses from its initial formation to its mature state.
|
1 | Q99PV8 (/IMP) |
|
Axonogenesis GO:0007409
De novo generation of a long process of a neuron, including the terminal branched region. Refers to the morphogenesis or creation of shape or form of the developing axon, which carries efferent (outgoing) action potentials from the cell body towards target cells.
|
1 | Q99PV8 (/IMP) |
|
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
1 | Q99PV8 (/IDA) |
|
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
|
1 | Q99PV8 (/IMP) |
|
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | Q99PV8 (/IMP) |
|
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | D3ZSY3 (/IMP) |
|
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | Q9QYE3 (/ISO) |
|
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | Q9QYE3 (/IMP) |
|
Regulation of keratinocyte proliferation GO:0010837
Any process that modulates the rate, frequency or extent of keratinocyte proliferation. Keratinocyte proliferation is the multiplication or reproduction of keratinocytes, resulting in the expansion of a cell population.
|
1 | Q99PV8 (/IMP) |
|
Positive regulation of neuron projection development GO:0010976
Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
1 | Q9QYE3 (/ISO) |
|
Negative regulation of neuron projection development GO:0010977
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
1 | Q9QYE3 (/ISO) |
|
Protein sumoylation GO:0016925
The process in which a SUMO protein (small ubiquitin-related modifier) is conjugated to a target protein via an isopeptide bond between the carboxy-terminus of SUMO with an epsilon-amino group of a lysine residue of the target protein.
|
1 | Q9QYE3 (/IMP) |
|
Regulation of lipid metabolic process GO:0019216
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving lipids.
|
1 | Q99PV8 (/IMP) |
|
Striatal medium spiny neuron differentiation GO:0021773
The process in which a relatively unspecialized cell acquires specialized features of a medium spiny neuron residing in the striatum.
|
1 | Q99PV8 (/IMP) |
|
Commitment of neuronal cell to specific neuron type in forebrain GO:0021902
The commitment of neuronal precursor cells to become specialized types of neurons in the forebrain.
|
1 | Q99PV8 (/IGI) |
|
Central nervous system neuron differentiation GO:0021953
The process in which a relatively unspecialized cell acquires specialized features of a neuron whose cell body resides in the central nervous system.
|
1 | Q99PV8 (/IGI) |
|
B cell differentiation GO:0030183
The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
|
1 | Q9QYE3 (/IMP) |
|
T cell differentiation GO:0030217
The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.
|
1 | Q9QYE3 (/IMP) |
|
Regulation of B cell proliferation GO:0030888
Any process that modulates the frequency, rate or extent of B cell proliferation.
|
1 | A2VDW9 (/ISS) |
|
Post-embryonic camera-type eye development GO:0031077
The process occurring during the post-embryonic phase whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure.
|
1 | Q99PV8 (/IMP) |
|
T cell differentiation in thymus GO:0033077
The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus.
|
1 | Q99PV8 (/IMP) |
|
T cell receptor V(D)J recombination GO:0033153
The process in which T cell receptor V, D, and J, or V and J gene segments, depending on the specific locus, are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS).
|
1 | Q99PV8 (/IMP) |
|
Hematopoietic stem cell migration GO:0035701
The orderly movement of a hematopoietic stem cell from one site to another. A hematopoietic stem cell is a cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system.
|
1 | Q99PV8 (/ISO) |
|
Hematopoietic stem cell migration GO:0035701
The orderly movement of a hematopoietic stem cell from one site to another. A hematopoietic stem cell is a cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system.
|
1 | Q99PV8 (/ISS) |
|
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
|
1 | Q99PV8 (/IMP) |
|
Regulation of apoptotic process GO:0042981
Any process that modulates the occurrence or rate of cell death by apoptotic process.
|
1 | A2VDW9 (/ISS) |
|
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
1 | Q99PV8 (/IMP) |
|
Positive T cell selection GO:0043368
The process of sparing immature T cells which react with self-MHC protein complexes with low affinity levels from apoptotic death.
|
1 | Q99PV8 (/IMP) |
|
Skin development GO:0043588
The process whose specific outcome is the progression of the skin over time, from its formation to the mature structure. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner vascular dermis (cutis, corium or true skin) composed mostly of connective tissue.
|
1 | Q99PV8 (/IMP) |
|
Regulation of B cell differentiation GO:0045577
Any process that modulates the frequency, rate or extent of B cell differentiation.
|
1 | A2VDW9 (/ISS) |
|
Regulation of lymphocyte differentiation GO:0045619
Any process that modulates the frequency, rate or extent of lymphocyte differentiation.
|
1 | A2VDW9 (/ISS) |
|
Regulation of neuron differentiation GO:0045664
Any process that modulates the frequency, rate or extent of neuron differentiation.
|
1 | Q99PV8 (/IMP) |
|
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | Q99PV8 (/IGI) |
|
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | Q99PV8 (/ISO) |
|
Alpha-beta T cell differentiation GO:0046632
The process in which a precursor cell type acquires the specialized features of an alpha-beta T cell. An alpha-beta T cell is a T cell that expresses an alpha-beta T cell receptor complex.
|
1 | Q99PV8 (/IMP) |
|
Thymus development GO:0048538
The process whose specific outcome is the progression of the thymus over time, from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells, with unique vascular, nervous, epithelial, and lymphoid cell components.
|
1 | Q99PV8 (/IMP) |
|
Negative regulation of collateral sprouting GO:0048671
Any process that stops, prevents, or reduces the frequency, rate or extent of collateral sprouting.
|
1 | Q9QYE3 (/ISO) |
|
Positive regulation of collateral sprouting GO:0048672
Any process that activates or increases the frequency, rate or extent of collateral sprouting.
|
1 | Q9QYE3 (/ISO) |
|
Regulation of dendrite development GO:0050773
Any process that modulates the frequency, rate or extent of dendrite development.
|
1 | Q9QYE3 (/ISO) |
|
Olfactory bulb axon guidance GO:0071678
The process in which the migration of an axon growth cone of a neuron in the olfactory bulb is directed to its target in the brain in response to a combination of attractive and repulsive cues.
|
1 | Q99PV8 (/IMP) |
|
Lymphoid lineage cell migration into thymus GO:0097535
The movement of a lymphoid lineage cell (also called a lymphoid lineage restricted progenitor cell) into the thymus. Lymphoid lineage cells enter and exit the thymus several times as part of this process.
|
1 | Q99PV8 (/ISO) |
|
Lymphoid lineage cell migration into thymus GO:0097535
The movement of a lymphoid lineage cell (also called a lymphoid lineage restricted progenitor cell) into the thymus. Lymphoid lineage cells enter and exit the thymus several times as part of this process.
|
1 | Q99PV8 (/ISS) |
|
Negative regulation of dendrite extension GO:1903860
Any process that stops, prevents or reduces the frequency, rate or extent of dendrite extension.
|
1 | D3ZSY3 (/IMP) |
|
Negative regulation of dendrite extension GO:1903860
Any process that stops, prevents or reduces the frequency, rate or extent of dendrite extension.
|
1 | Q9QYE3 (/ISO) |
|
Negative regulation of neuron remodeling GO:1904800
Any process that stops, prevents or reduces the frequency, rate or extent of neuron remodeling.
|
1 | D3ZSY3 (/IMP) |
|
Negative regulation of neuron remodeling GO:1904800
Any process that stops, prevents or reduces the frequency, rate or extent of neuron remodeling.
|
1 | Q9QYE3 (/ISO) |
|
Cellular response to L-glutamate GO:1905232
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a L-glutamate(1-) stimulus.
|
1 | D3ZSY3 (/IEP) |
|
Negative regulation of dendrite development GO:2000171
Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development.
|
1 | D3ZSY3 (/IMP) |
|
Negative regulation of dendrite development GO:2000171
Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development.
|
1 | Q9QYE3 (/ISO) |
|
Negative regulation of branching morphogenesis of a nerve GO:2000173
Any process that stops, prevents, or reduces the frequency, rate or extent of branching morphogenesis of a nerve.
|
1 | D3ZSY3 (/IMP) |
|
Negative regulation of branching morphogenesis of a nerve GO:2000173
Any process that stops, prevents, or reduces the frequency, rate or extent of branching morphogenesis of a nerve.
|
1 | Q9QYE3 (/ISO) |
There are 14 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
| GO Term | Annotations | Evidence |
|---|---|---|
|
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
55 |
D6W5D9 (/IDA)
D6W5D9 (/IDA)
D6W5D9 (/IDA)
D6W5D9 (/IDA)
D6W5D9 (/IDA)
D6W5D9 (/IDA)
D6W5D9 (/IDA)
D6W5D9 (/IDA)
D6W5D9 (/IDA)
D6W5D9 (/IDA)
(45 more) |
|
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
17 |
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
Q13422 (/IMP)
(7 more) |
|
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
16 |
D3ZSY3 (/IDA)
P81183 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
(6 more) |
|
Nuclear pericentric heterochromatin GO:0031618
Nuclear heterochromatin that is located adjacent to the CENP-A rich centromere 'central core' and characterized by the modified histone H3K9me3.
|
12 |
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
(2 more) |
|
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
|
12 |
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
Q13422 (/IDA)
(2 more) |
|
Nuclear body GO:0016604
Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
|
11 |
F8VPL6 (/IDA)
F8VPL6 (/IDA)
F8VPL6 (/IDA)
F8VPL6 (/IDA)
F8VPL6 (/IDA)
Q9H2S9 (/IDA)
Q9H2S9 (/IDA)
Q9H2S9 (/IDA)
Q9H2S9 (/IDA)
Q9H2S9 (/IDA)
(1 more) |
|
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
5 | Q9H2S9 (/TAS) Q9H2S9 (/TAS) Q9H2S9 (/TAS) Q9H2S9 (/TAS) Q9H2S9 (/TAS) |
|
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | Q9QYE3 (/ISO) |
|
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
1 | Q9QYE3 (/ISO) |
|
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | D3ZSY3 (/IDA) |
|
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | Q9QYE3 (/ISO) |
|
Postsynaptic density GO:0014069
An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
|
1 | D3ZSY3 (/IDA) |
|
Postsynaptic density GO:0014069
An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
|
1 | Q9QYE3 (/ISO) |
|
Neuron projection GO:0043005
A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
|
1 | Q99PV8 (/IDA) |